(Reuters) -Indian pharmaceutical stocks shed 1.3% on Monday, even as the broader markets rose, after U.S. President Donald ...

The other factor that the industry is watching out for is the imposition of tariffs on drug imports in to the US, on which ...

Shares of Indian pharmaceutical companies fell up to 7% after US President Donald Trump promised to sign an executive order ...

Shares of Asian pharmaceutical companies fell after US President Donald Trump said he planned to order a cut in US ...

Now, this won't come as too much of a surprise to Eli Lilly and its peers. A few weeks ago, the company's CEO, David Ricks, ...

The richest sliver of Americans now own a record share of the wealth, and tweaking income taxes is unlikely to change that.

President Donald Trump posted on his social media platform, Truth Social, on Sunday, saying Israeli-American hostage Edan ...

On Sunday, secretary of the treasury Scott Bessent revealed that there had been 'substantial progress between the United ...

U.S. President Donald Trump said on Sunday he would sign an executive order that he said would reduce prescription drug and ...

Walmart's CEO told Trump his tariffs could affect global supply chains and "lead to empty shelves." Does that spell bad news ...

The BSE pharma index slipped 333 points in early deals to 40,889 against the previous close of Rs 41,222.  On similar lines, ...

Two scoops to start: Millennium Management is talking with Goldman Sachs ’ Petershill Partners to identify potential buyers for a minority equity stake in Millennium’s management company, the latest ...